• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Egg Allergy Market Share

    ID: MRFR/Pharma/3312-CR
    85 Pages
    Rahul Gotadki
    June 2024

    Egg Allergy Market Research Report Information by Age Group (Children and Adults), Diagnosis & Treatment (Diagnosis [Skin Test, Blood Test, Food Challenge and others] and Treatment [Medication and Oral Immunotherapy]), End User (Hospitals and Clinics, Diagnostic Centers, Research Institutes and others) - Forecast till 2030

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Egg Allergy Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Share

    Egg Allergy Market Share Analysis

    In the evolving landscape of the Egg Allergy Market, effective market share positioning strategies are crucial for companies seeking to establish their presence and succeed in a competitive environment. These strategies serve as a roadmap for navigating the complexities of the market, differentiating products, and capturing a significant portion of market share. One pivotal strategy revolves around product innovation and differentiation. Companies in this sector strive to develop allergy treatments and alternatives that offer superior efficacy, safety, and convenience compared to traditional solutions. By emphasizing factors such as effectiveness, minimal side effects, and ease of use, companies can appeal to healthcare providers and patients seeking reliable and user-friendly options, thereby gaining traction and expanding their market share.

    Price positioning is another critical aspect of market share strategies within the Egg Allergy Market. Companies may employ various pricing strategies to gain a competitive edge and capture market share. Some may opt for a premium pricing strategy, positioning their allergy treatments as high-quality products associated with superior outcomes and patient satisfaction. This approach resonates with patients who prioritize quality and are willing to invest in effective solutions. Conversely, other companies may adopt a more aggressive pricing approach, offering their products at a lower price point to penetrate new market segments or appeal to cost-conscious buyers. By strategically adjusting pricing strategies, companies can effectively position themselves within the market and attract a broader customer base.

    Distribution channels play a pivotal role in market share positioning strategies within the Egg Allergy Market. Companies must ensure their products are readily available and accessible to healthcare facilities, pharmacies, and patients through various channels. This involves establishing partnerships with distributors, specialty allergy clinics, and online retailers to ensure widespread availability and reach. Additionally, companies may leverage direct-to-consumer sales channels and e-commerce platforms to connect with patients directly and streamline the purchasing process. By optimizing distribution channels, companies can enhance their visibility, expand their market reach, and effectively compete for market share.

    Marketing and branding strategies also play a significant role in market share positioning within the Egg Allergy Market. Companies need to develop compelling marketing campaigns that resonate with healthcare professionals and patients and differentiate their brands from competitors. This may involve leveraging digital marketing channels, social media platforms, and educational materials to raise awareness about the benefits of their products. Additionally, companies may collaborate with healthcare providers, patient advocacy groups, and influencers to promote their treatments and establish credibility within the industry. By crafting a strong brand identity and communicating value propositions effectively, companies can differentiate themselves in the market and drive market share growth.

    Furthermore, strategic partnerships and collaborations can have a substantial impact on market share positioning in the Egg Allergy Market. Companies may form alliances with food manufacturers, research institutions, and allergy clinics to drive innovation, expand product offerings, and access new markets. By leveraging complementary strengths and resources, companies can enhance their competitive position, accelerate market penetration, and solidify their position as industry leaders. Strategic partnerships also enable companies to leverage existing distribution channels, amplify marketing efforts, and achieve economies of scale, ultimately leading to increased market share.

    Market Summary

    The Global Egg Allergy Market is projected to grow from 1.48 USD Billion in 2024 to 2.81 USD Billion by 2035, reflecting a robust growth trajectory.

    Key Market Trends & Highlights

    Global Egg Allergy Key Trends and Highlights

    • The market is expected to expand at a compound annual growth rate (CAGR) of 6.0 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 2.81 USD Billion, indicating a substantial increase from the base year.
    • In 2024, the market is valued at 1.48 USD Billion, laying a strong foundation for future growth.
    • Growing adoption of allergen-free food products due to rising awareness of food allergies is a major market driver.

    Market Size & Forecast

    2024 Market Size 1.48 (USD Billion)
    2035 Market Size 2.81 (USD Billion)
    CAGR (2025-2035) 6.0%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    Genentech, Inc. (the US), Sanofi SA (France), ImmuneTech (US), Quest Diagnostics (US), HYCOR Biomedical (US), Alletess Medical Laboratory (US), Kaleo, Inc. (the US), Imutest Ltd (UK), Creative Diagnostics (US), Impax Laboratories (US), Mylan NV (US)

    Market Trends

    Major drivers of the market

    The egg allergy market size is evolving at a faster pace, and in the upcoming times, it will grow immensely. The number of cases of egg allergies is increasing day by day, both in adults as well as infants. Most number of cases over the years has happened to children more than egg allergy in adults. Symptoms of egg allergy in children outgrow way before it results in egg allergy symptoms in adults. The food allergy prevalence has increased to a greater extent which acts as a driving force for the growth of the global egg allergy market.

    Several technological advancements in egg allergy medication and treatment resulted in propelling the egg allergy market size. 

    The technological advancements in egg allergy treatment and diagnosis methods include skin prick test, food challenge, blood test, oral immunotherapy, and many more. These advanced methods of treatment increase the skin allergy test market size and help to propagate the growth of the egg allergy market to the optimum level in the forecast period.

    Significant growth opportunities for the market

    The egg allergy market is increasing to greater heights in a short time span, and the market will continue to grow in the future due to an extreme increase in egg allergy cases. The skin allergy test market size is rising exponentially with the advanced technological methods of diagnosis and treatment. These advancements are not just limited to egg allergy treatment but also include advancements in the identification process and screening. Various food scanners, apps, portable devices, and wearable are helpful in determining different food ingredients related to egg allergy.

    These devices are major opportunities for increasing the egg allergy industry size in the upcoming years.

    Market restraints

    The global egg allergy market is definitely growing at a faster rate, but the market growth can be hindered due to a lack of awareness among patients. The developing countries tend to avoid allergies, and the reason behind it lacks awareness. Many patients overlook the allergies and do not take any egg allergy treatment on time. The egg allergy cases in these countries are comparatively low, and the poor healthcare sector is also responsible for the same. Another prime restraint for the egg allergy industry is the hefty cost involved in the diagnosis and treatment process.

    Many tests are also not covered by any insurance policies. Such constraints restrict the growth of the egg allergy market size.

    Market Growth Challenges

    The egg allergy market is immensely dependent on the number of cases of egg allergy patients. Many patients overlook and avoid egg allergy medication in time which leads to declining market growth. Various tests like radioallergosorbent test (RAST) and enzyme-linked immunosorbent assay (ELISA or EIA) has their own limitations, which sometimes show false results and diagnosis failure due to cross-contamination. These testing procedures also require proficient egg allergy industry therapeutics who can handle the tests properly, which hinders the market growth of the egg allergy market size.

    Value Chain Analysis

    The revenue of the egg allergy industry is continuously escalating over the years and will continue to grow in the forecast years. Various egg research and consultancy sectors are focusing on the prevention and cure of the disease. The continuous effort for producing better egg allergy medication has resulted in the increasing the market value of the egg allergy market. The expansion of skin allergy test market size will reach greater levels in the upcoming years.

    The prevalence of egg allergy among children appears to be on the rise, necessitating increased awareness and management strategies to address this growing public health concern.

    Centers for Disease Control and Prevention (CDC)

    Egg Allergy Market Market Drivers

    Rising Prevalence of Egg Allergy

    The increasing incidence of egg allergy, particularly among children, is a primary driver of the Global Global Egg Allergy Market Industry. Studies indicate that egg allergy affects approximately 1.5 to 2.5 percent of children globally, with many outgrowing it by adolescence. However, the persistent cases contribute to a growing demand for allergen-free products. As awareness of food allergies rises, parents and caregivers are more vigilant, leading to increased consumption of egg-free alternatives. This trend is expected to propel the market, with projections estimating the market value to reach 1.48 USD Billion in 2024.

    Market Segment Insights

    Egg Allergy Age Group Insights

    The egg allergy industry size segmentation on the basis of age group includes children and adults. The egg allergy symptoms in adults are very less compared to children, so the children have the largest share in the egg allergy industry. 

    Egg Allergy Treatment Insights

    The treatment segment consists of sub-segments that include egg allergy medication and oral immunotherapy process, whereas the diagnosis segment consists of tests like blood tests, skin tests, and others.

    Egg Allergy end-user Insights

    Egg allergy market segmentation on the basis of end-user comprises hospitals and clinics, egg research and consultancy, and diagnostics centers. 

    Get more detailed insights about Egg Allergy Market by Share, Size, Growth and Overview – 2030

    Regional Insights

    Key Companies in the Egg Allergy Market market include

    Industry Developments

    Future Outlook

    Egg Allergy Market Future Outlook

    The Global Egg Allergy Market is projected to grow at a 6.0% CAGR from 2024 to 2035, driven by rising awareness, innovative treatments, and increasing prevalence of allergies.

    New opportunities lie in:

    • Develop personalized dietary solutions for egg allergy patients.
    • Invest in research for novel immunotherapy treatments.
    • Expand product lines to include egg-free alternatives in mainstream markets.

    By 2035, the market is expected to demonstrate robust growth, reflecting heightened consumer demand and innovative solutions.

    Market Segmentation

    Report Scope

    Attribute/Metric Details
    Market Size USD 2.01643 Billion by 2030
    CAGR 6.90% (2022-2030)
    Base Year   2021
    Forecast Period   2022-2030
    Historical Data   2020
    Forecast Units   Value (USD Billion)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered Types, end user, Region
    Geographies Covered America, Europe, Asia Pacific, Middle East and Africa
    Key Vendors Genentech Inc. (the US), Sanofi SA (France), ImmuneTech (US), Quest Diagnostics (US), HYCOR Biomedical (US), Alletess Medical Laboratory (US), Kaleo Inc. (the US), Imutest Ltd (UK), Creative Diagnostics (US), Impax Laboratories (US), Mylan NV (US)

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    At what CAGR is the global egg allergy market projected to grow in the forecast period (2024-2032)?

    Egg allergy market projected to grow at approximately 6.90% CAGR during the assessment period (2022-2030).

    How much is the global egg allergy market worth in the future?

    The valuation of the global egg allergy market is estimated to increase to USD 2.016 Billion by the end of 2030

    What are the major tailwinds pushing the growth of the global egg allergy market?

    Increasing prevalence, improved allergy diagnosis, and rising healthcare expenses are major tailwinds pushing the growth of the global egg allergy market.

    Which region holds the largest share in the global egg allergy market?

    North America holds the largest share in the global egg allergy market, followed by Europe and the Asia Pacific, respectively.

    Who are the top players in the global egg allergy market?

    Genetech, Inc. (US), Mylan N.V. (US), Sanofi (France), Alletess Medical Laboratory (US), Creative Diagnostics (US), HYCOR Biomedical (US), Impax Laboratories, Inc. (US), Kaleo, Inc. (US), Kaleo, Inc. (US), Impax Laboratories (US), Quest Diagnostics (US), ImmuneTech (US), and Imutest Ltd. (UK), are some of the top players operating in the global egg allergy market.

    1. 'TABLE OF CONTENT     Chapter 1.    Report Prologue    
    2. Chapter 2.    Market Introduction    
      1.     Definition    
      2.   
    3.  Scope of the Study    
      1.     Research Objective    
        1.     Assumptions    
        2.     Limitations     Chapter
      2.     Introduction
      3.     Primary Research    
      4.     Secondary research    
      5.     Market Size Estimation
    4. Chapter 4.    Market Dynamics
      1.     Drivers    
      2.     Restrains
      3.     Opportunities    
      4.     Challenges
      5.     Macroeconomic Indicators
      6.     Technology
    5. Trends & Assessment            
    6. Chapter 5.    Market Factor Analysis
      1.     Porter’s Five Forces Analysis
        1.     Bargaining Power of Suppliers    
        2.     Bargaining Power of Buyers
        3.   
    7.  Threat of New Entrants    
      1.     Threat of Substitutes    
        1.     Intensity of Rivalry    
      2.     Value Chain Analysis
      3.     Investment Feasibility Analysis    
      4.     Pricing Analysis
    8. Chapter 6.    Global Encephalomyelitis Market, by Type          6.1    Introduction
      1.     Acute Disseminated Encephalomyelitis
    9. Market Estimates & Forecast
    10. 2020 – 2027
      1.     Encephalomyelitis Disseminata Market
    11. Estimates & Forecast, 2020 – 2027
      1.     Deprivation & Occlusion Encephalomyelitis
    12. Market Estimates & Forecast, 2020 –
      1.     AntiMOG Associated Encephalomyelitis Market
    13. Estimates & Forecast, 2020 – 2027
      1.     Equine Encephalomyelitis
    14. Market Estimates & Forecast, 2020 – 2027
      1.     AIDS Related Encephalomyelitis
    15. Market Estimates & Forecast, 2020 – 2027
    16.         6.8    Others Chapter
      1.     Drug Treatment
    17. Market Estimates & Forecast, 2020 – 2027
      1.     Antiviral Medications
        1.     Antibiotics
        2.     Steroids
        3.     Sedatives
        4.     NSAIDs
        5.     Mood Stabilizers
        6.     Others
      2.     Plasmapheresis Market Estimates
    18. Forecast, 2020 – 2027
      1.     Surgery Market Estimates
    19. & Forecast, 2020 – 2027
      1.     Others Chapter
      2.     Introduction
      3.     Hospitals Market Estimates
    20. Forecast, 2020 – 2027
      1.     Clinics Market Estimates
    21. & Forecast, 2020 – 2027
      1.     Others Chapter
      2.     Introduction
      3.     America
        1.     North America
        2.     South America
      4.     Europe
        1.     Western Europe
        2.     Eastern Europe
      5.     Asia Pacific
        1.     Japan
        2.     China
        3.     India
        4.     Australia
        5.     Republic of Korea
        6.     Rest of Asia Pacific
      6.   
    22.  The Middle East & Africa
      1.     United Arab Emirates
        1.      Saudi Arabia
        2.     Oman
        3.     Kuwait
        4.     Qatar
        5.     Rest
    23. of the Middle East & Africa
    24. Chapter 10    Company Landscape    
      1.     Introduction    
      2.   
    25.  Market Share Analysis    
      1.     Key Development & Strategies    
        1.     Key Developments    
    26. Chapter 11    Company Profiles    
      1.     Bristol-Myers Squibb Company     
        1.     Company Overview    
        2.     Product Overview    
        3.     Financials    
        4.     SWOT Analysis    
      2.     Sanofi     
        1.     Company Overview    
        2.     Product Overview    
        3.     Financial Overview    
        4.     Key Developments    
        5.     SWOT Analysis    
      3.     GlaxoSmithKline Plc.    
        1.     Company Overview    
        2.     Product Overview    
        3.     Financial Overview
        4.     Key Development    
        5.     SWOT Analysis    
      4.     Amgen, Inc
        1.     Company Overview    
        2.     Product/Business Segment Overview    
        3.     Financial Overview    
        4.     Key Development    
        5.     SWOT Analysis    
      5.     Bayer AG
        1.     Company Overview    
        2.     Product Overview    
        3.     Financial overview    
        4.     Key Developments    
      6.   
    27.  Novartis AG     
      1.     Company Overview    
        1.     Product Overview    
        2.     Financial Overview    
        3.     Key Developments    
      2.     F. Hoffmann-La Roche Ltd
        1.     Overview    
        2.     Product Overview    
        3.     Financials    
        4.     Key Developments    
        5.     SWOT Analysis         11.8    Others Chapter 12    MRFR Conclusion    
      3.     Key Findings    
        1.     From CEO’s View Point    
        2.     Unmet Needs of the Market    
      4.   
    28.  Key Companies to Watch    
      1.     Prediction of Pharmaceutical Industry Chapter 13    Appendix DATA
    29. Synopsis, 2020 – 2027
    30. Encephalomyelitis Market Estimates and Forecast, 2020 – 2027, (USD Million)
    31. Region, 2020 – 2027, (USD Million)
    32.  Global Encephalomyelitis Market by Types, 2020 – 2027, (USD Million)
    33. Treatment, 2020 – 2027, (USD Million)
    34.  Global Encephalomyelitis Market by End Users, 2020 – 2027, (USD Million)
    35. by Types, 2020 – 2027, (USD Million)
    36.  North America Encephalomyelitis Market by Treatment, 2020 – 2027, (USD Million)
    37. Market by End Users, 2020 – 2027, (USD Million)
    38.  US Market by Types, 2020 – 2027, (USD Million)
    39.  US Encephalomyelitis Market by Treatment, 2020 – 2027, (USD Million) 2027, (USD Million)
    40. – 2027, (USD Million)
    41. Market by Treatment, 2020 – 2027, (USD Million)
    42.  Canada Encephalomyelitis Market by End Users, 2020 – 2027, (USD Million) Million)
    43. by Treatment, 2020 – 2027, (USD Million)
    44. America Encephalomyelitis Market by End Users, 2020 – 2027, (USD Million)
    45. – 2027, (USD Million)
    46. Market by End Users, 2020 – 2027, (USD Million)
    47.  Western Europe Market by Types, 2020 – 2027, (USD Million)
    48. 23    Western Europe Encephalomyelitis Market by Treatment, 2020
    49. – 2027, (USD Million)
    50. Market by End Users, 2020 – 2027, (USD Million)
    51.  Eastern Europe Market by Types, 2020 – 2027, (USD Million)
    52. 26    Eastern Europe Encephalomyelitis Market by Treatment, 2020
    53. – 2027, (USD Million)
    54. Market by End Users, 2020 – 2027, (USD Million)
    55.  Asia Pacific Market by Types, 2020 – 2027, (USD Million)
    56. 29    Asia Pacific Encephalomyelitis Market by Treatment, 2020 – 2027, (USD Million)
    57. Market by End Users, 2020 – 2027, (USD Million)
    58.  Middle East & Africa Market by Types, 2020 – 2027, (USD Million)
    59. Treatment, 2020 – 2027, (USD Million)
    60. East & Africa Encephalomyelitis Market by End Users, 2020 – 2027, (USD Million) Process Market Market type 2020 by Treatment 2020
    61. Share, by End Users, 2020
    62. Market Share, by Region, 2020
    63. Market Share, by Country, 2020
    64. Market Share, by Country, 2020
    65. Market Share, by Country, 2020
    66. Africa Encephalomyelitis Market Share, by Country, 2020
    67.  Global Encephalomyelitis Market: Company Share Analysis, 2020 (%)
    68. 13    Bristol-Myers Squibb Company: Key Financials
    69.  Bristol-Myers Squibb Company: Segmental Revenue
    70.  Bristol-Myers Squibb Company: Geographical Revenue  Sanofi: Key Financials Revenue
    71. 19    GlaxoSmithKline Plc.: Key Financials
    72.  GlaxoSmithKline Plc.: Segmental Revenue Plc.: Geographical Revenue
    73.  Amgen, Inc: Geographical Revenue Key Financials
    74. 27    Bayer AG: Geographical Revenue
    75. AG : Key Financials
    76.  F. Hoffmann-La Roche Ltd: Key Financials
    77. Hoffmann-La Roche Ltd: Segmental Revenue
    78. Roche Ltd: Geographical Revenue'

    Egg Allergy Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials